arsenic trioxide has been researched along with Necrosis in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 10 (41.67) | 29.6817 |
| 2010's | 10 (41.67) | 24.3611 |
| 2020's | 3 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Ammatuna, E; Diepstra, A; Hazenberg, CLE; Huls, GA; Santing, M | 1 |
| Gavali, S; Linkermann, A; Tonnus, W | 1 |
| Ahmadimoghaddam, D; Ataei, S; Gholami, A; Nili-Ahmadabadi, A; Omidifar, N | 1 |
| Du, YY; Luo, Y; Sun, GB; Sun, XB; Wang, M; Wang, W; Yu, YL; Zhang, JY | 1 |
| Brandt-Rauf, P; Cassai, N; Dinnen, RD; Fine, RL; Mao, Y; Nichols, G; Qiu, W; Slavkovich, VN; Su, GH | 1 |
| Chen, Y; Li, P; Tong, N; Yang, S; Zhang, J; Zhao, X | 1 |
| Chen, G; Sung, PT | 1 |
| Chen, YR; Dou, MM; Li, PC; Yang, S; Zhang, J; Zhao, XY | 1 |
| Diemer, F; Marty, M; Noirrit-Esclassan, E | 1 |
| Bai, X; Cai, BZ; Li, JX; Li, XQ; Lu, YJ; Shen, YQ; Zhao, J | 1 |
| Berthou, C; Charles, F; Eveillard, JR; Ianotto, JC; Tempescul, A | 1 |
| Gu, N; Li, GZ; Lu, Q; Niu, HZ; Teng, GJ; Wang, ZY; Xu, RZ; Yu, H; Zhang, DS; Zhu, GY | 1 |
| Armistead, MY; Cohenford, M; Murray, E; Selvaraj, V | 1 |
| Chim, CS; Kam, S; Kwong, YL; Lam, CC; Man, C; Wong, KF | 1 |
| Cheng, LC; Liang, YC; Ou, BR; Yeh, JY | 1 |
| Hara, S; Ishitsuka, K; Iwao, Y; Shirahashi, A; Shishime, M; Suzumiya, J; Takamatsu, Y; Takatsuka, Y; Tamura, K; Utsunomiya, A | 1 |
| Meng, R; Sui, XH; Yang, BF; Zhou, J | 1 |
| Daniel, PT; Dörken, B; Essmann, F; Scholz, C; Schulze-Osthoff, K; Stärck, L; Wieder, T | 1 |
| Gogvadze, V; McConkey, DJ; Mirnikjoo, B; Nutt, LK; Orrenius, S; Uthaisang, W | 1 |
| Allen, T; Rana, SV | 1 |
| Horváth, V; Ondrousková, E; Smarda, J; Soucek, K | 1 |
| Jonas, JB; Li, B; Li, W; Shi, G; Wang, C; Zhang, H | 1 |
| Bareau, B; Corolleur, M; Fardel, O; Fest, T; Morzadec, C; van Grevenynghe, J; Vernhet, L | 1 |
| Brown, SL; Griffin, RJ; Kim, JH; Lew, YS; Song, CW | 1 |
1 review(s) available for arsenic trioxide and Necrosis
| Article | Year |
|---|---|
Arsenic trioxide-induced osteo-necrosis treatment in a child: mini-review and case report.
Topics: Adolescent; Arsenic Trioxide; Arsenicals; Dental Materials; Dental Pulp Devitalization; Dental Pulp Necrosis; Female; France; Gingival Diseases; Humans; Mandibular Diseases; Necrosis; Osteonecrosis; Oxides; Pulpectomy | 2016 |
23 other study(ies) available for arsenic trioxide and Necrosis
| Article | Year |
|---|---|
Bone marrow necrosis as complication of treatment with all-trans retinoic acid and arsenic trioxide: case report and implications for treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Bone Marrow; Humans; Leukemia, Promyelocytic, Acute; Necrosis; Tretinoin | 2022 |
Immunological consequences of arsenic trioxide-induced necrosis.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Humans; Necrosis | 2023 |
Pentoxifylline Attenuates Arsenic Trioxide-Induced Cardiac Oxidative Damage in Mice.
Topics: Animals; Antineoplastic Agents; Antioxidants; Arsenic Trioxide; Cardiotoxicity; Heart Diseases; Lipid Peroxidation; Male; Malondialdehyde; Mice; Necrosis; Nitric Oxide; Oxidative Stress; Pentoxifylline; Vasodilator Agents | 2021 |
Salvianolic Acid A Protects H9c2 Cells from Arsenic Trioxide-Induced Injury via Inhibition of the MAPK Signaling Pathway.
Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Caffeic Acids; Cardiotonic Agents; Cell Line; Cell Survival; Extracellular Signal-Regulated MAP Kinases; Lactates; MAP Kinase Signaling System; Necrosis; Oxides; Proto-Oncogene Proteins c-bcl-2; Rats; Up-Regulation | 2017 |
Redirecting apoptosis to aponecrosis induces selective cytotoxicity to pancreatic cancer cells through increased ROS, decline in ATP levels, and VDAC.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Ascorbic Acid; Cell Line, Tumor; Disease Models, Animal; Disulfiram; Dose-Response Relationship, Drug; Heterografts; Humans; Male; Mice; Necrosis; Oxides; Pancreatic Neoplasms; Reactive Oxygen Species; Tumor Stem Cell Assay; Voltage-Dependent Anion Channels | 2013 |
Tetrandrine enhances the anticancer effects of arsenic trioxide in vitro.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Benzylisoquinolines; Cell Cycle Checkpoints; Cell Proliferation; Dose-Response Relationship, Drug; Drug Synergism; HeLa Cells; Hep G2 Cells; Humans; Necrosis; Neoplasms; Oxides; Time Factors | 2014 |
Gingival and localized alveolar bone necrosis related to the use of arsenic trioxide paste--two case reports.
Topics: Adult; Alveolar Process; Arsenic Trioxide; Arsenicals; Dental Materials; Dental Pulp Devitalization; Female; Gingival Diseases; Humans; Mandibular Diseases; Middle Aged; Necrosis; Osteonecrosis; Oxides | 2014 |
Resveratrol and arsenic trioxide act synergistically to kill tumor cells in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Drug Synergism; Humans; Male; Mice; Necrosis; Neovascularization, Pathologic; Oxides; Reactive Oxygen Species; Resveratrol; Stilbenes; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
Arsenic trioxide induces the apoptosis in vascular smooth muscle cells via increasing intracellular calcium and ROS formation.
Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Calcium; Dose-Response Relationship, Drug; Egtazic Acid; In Situ Nick-End Labeling; L-Lactate Dehydrogenase; Microscopy, Fluorescence; Muscle, Smooth, Vascular; Necrosis; Oxides; Rats; Reactive Oxygen Species | 2010 |
Non-lethal bone marrow necrosis under first-line arsenic trioxide therapy in acute promyelocytic leukaemia.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Bone Marrow; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Necrosis; Oxides; Treatment Outcome | 2010 |
Arterial embolization hyperthermia using As2O3 nanoparticles in VX2 carcinoma-induced liver tumors.
Topics: Angiography; Animals; Arsenic Trioxide; Arsenicals; Embolization, Therapeutic; Hyperthermia, Induced; Immunohistochemistry; Liver; Liver Function Tests; Liver Neoplasms; Male; Microvessels; Nanoparticles; Necrosis; Oxides; Platelet Endothelial Cell Adhesion Molecule-1; Rabbits; Survival Analysis; Temperature; Tomography, X-Ray Computed; Treatment Outcome; Vascular Endothelial Growth Factor A | 2011 |
Arsenic trioxide (As(2)O(3)) induces apoptosis and necrosis mediated cell death through mitochondrial membrane potential damage and elevated production of reactive oxygen species in PLHC-1 fish cell line.
Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line; Fishes; Membrane Potential, Mitochondrial; Mitochondria; Necrosis; Oxides; Reactive Oxygen Species; Water Pollutants, Chemical | 2013 |
Atypical blasts and bone marrow necrosis associated with near-triploid relapse of acute promyelocytic leukemia after arsenic trioxide treatment.
Topics: Adult; Arsenic Trioxide; Arsenicals; Biopsy; Bone Marrow; Chromosome Aberrations; Fatal Outcome; Female; Humans; Karyotyping; Leukemia, Promyelocytic, Acute; Necrosis; Oxides; Ploidies; Recurrence | 2002 |
Modulation of the arsenic effects on cytotoxicity, viability, and cell cycle in porcine endothelial cells by selenium.
Topics: Animals; Apoptosis; Arsenates; Arsenic; Arsenic Trioxide; Arsenicals; Arsenites; Caspase 3; Caspases; Cell Cycle; Cell Survival; Cells, Cultured; Cytotoxins; Dose-Response Relationship, Drug; Drug Interactions; Endothelial Cells; Glutathione Peroxidase; Interphase; Necrosis; Oxides; Selenium; Sodium Compounds; Sus scrofa; Tumor Suppressor Protein p53 | 2003 |
Bone marrow necrosis in a patient with acute promyelocytic leukemia during re-induction therapy with arsenic trioxide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Bone Marrow; Bone Marrow Diseases; Fever; Humans; Hydroxyurea; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Middle Aged; Necrosis; Oxides; Pancytopenia; Remission Induction | 2004 |
Repeated arsenic trioxide intravenous infusion causes focal bone marrow necrosis in two acute promyelocytic leukemia patients.
Topics: Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Bone Marrow; Bone Marrow Diseases; Child; Female; Humans; Infusions, Intravenous; Leukemia, Promyelocytic, Acute; Male; Necrosis; Oxides | 2004 |
Arsenic trioxide triggers a regulated form of caspase-independent necrotic cell death via the mitochondrial death pathway.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; bcl-X Protein; Caspase 2; Caspase 9; Caspases; Cell Death; Cell Line, Tumor; Fibroblasts; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Mitochondria; Necrosis; Oxides; Proto-Oncogene Proteins c-bcl-2 | 2005 |
Indirect effects of Bax and Bak initiate the mitochondrial alterations that lead to cytochrome c release during arsenic trioxide-induced apoptosis.
Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Caspase 3; Caspases; Cell Line, Transformed; Cell Transformation, Neoplastic; Cells, Cultured; Cytochrome c Group; Dose-Response Relationship, Drug; Embryo, Mammalian; Fibroblasts; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Mitochondria, Liver; Necrosis; Oxidative Stress; Oxides; Reactive Oxygen Species; Superoxides | 2005 |
Influence of thyroxine and n-propylthiouracil on nephro-toxicity of inorganic arsenic in rat.
Topics: Animals; Antithyroid Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Creatinine; Glomerulonephritis; Glutathione; Glutathione Transferase; Hyperthyroidism; Hypothyroidism; Kidney; Male; Necrosis; Oxides; Propylthiouracil; Rats; Rats, Wistar; Thyroxine; Triiodothyronine | 2006 |
Alternative pathways of programmed cell death are activated in cells with defective caspase-dependent apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Autophagy; Blotting, Western; Camptothecin; Caspases; Cell Line, Transformed; Cell Transformation, Neoplastic; Chickens; Cycloheximide; Genes, myb; Humans; Microscopy, Fluorescence; Necrosis; Oxides; Signal Transduction; U937 Cells | 2008 |
Effect of arsenic trioxide on uveal melanoma cell proliferation in vitro.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Flow Cytometry; Glutathione Peroxidase; Growth Inhibitors; Humans; Melanoma; Membrane Potentials; Microscopy, Electron; Mitochondria; Necrosis; Osmolar Concentration; Oxides | 2007 |
Inorganic arsenic induces necrosis of human CD34-positive haematopoietic stem cells.
Topics: Antigens, CD34; Arsenic Trioxide; Arsenicals; Cell Differentiation; Cell Lineage; Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Environmental Pollutants; Hematopoietic Stem Cells; Humans; Membrane Potential, Mitochondrial; Necrosis; Oxides | 2008 |
Arsenic trioxide causes selective necrosis in solid murine tumors by vascular shutdown.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Biological Transport; Disease Models, Animal; Fibrosarcoma; Male; Metabolic Clearance Rate; Methylcholanthrene; Mice; Mice, Inbred BALB C; Necrosis; Oxides; Perfusion | 1999 |